ALBANY, New York, December 1, 2015 /PRNewswire/ --
A new market study, titled "Contraceptives Market (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, Sub-Dermal Contraceptive Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020", has been released by Transparency Market Research (TMR).The report states that the global contraceptives market had a valuation of US$15.7 bn in 2013. Displaying a modest 3.1% CAGR between 2014 and 2020, the market is expected to be worth US$19.6 bn by 2020.
Browse the full Contraceptives Market (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, Sub-Dermal Contraceptive Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/contraceptives-market.html
The research report offers a top-level analysis of the growth of this market, which includes factors that are likely to support the growth of this market and also those that will challenge its growth. According to the report, increasing awareness about the use of contraceptives to prevent pregnancy and sexually transmitted infections (STIs) is the major factor driving the contraceptives market. In addition, initiatives taken by several governments and non-profit organizations around the world for improved maternal health, population control, and prevention of STIs are furthering growth of this market.
Get Sample Report Copy of Contraceptives Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344
To promote the use of contraceptives for their benefits and important role in public well-being, Bayer Healthcare, in association with a few NGOs, observes September 26th as World Contraception Day every year. Such drives have raised awareness about sexual and reproductive health among the masses, which, in turn, has led to higher demand for contraceptives.
Browse Press Release of Contraceptives Market: http://www.transparencymarketresearch.com/pressrelease/contraceptives-market.htm
The report divides the global contraceptives market on the basis of products and geography. On the basis of products, the market is segmented into drugs and devices. The drugs product segment is further segmented into contraceptive pills, contraceptive injectables, and topical contraceptives. Amongst all, contraceptive pills currently dominate the overall market for contraceptives. This is due to their high usage in North America, combined with their efficacy and ease of use for purposes such as preventing pregnancy.
Browse Article Of Contraceptives Market: http://www.transparencymarketresearch.com/article/contraceptives-market.htm
Among devices, the market is categorized into female and male contraceptive devices. Whilst male contraceptive devices comprise condoms, female contraceptive devices comprise products such as female condoms, contraceptive diaphragms, contraceptive vaginal rings, non-surgical permanent contraception devices, sub-dermal contraceptive implants, intrauterine devices (IUDs), and contraceptive sponges.
By product, contraceptive devices held the largest market share, which was almost 60% of the market in 2013. This is attributed to the popularity of devices such as male condoms, copper IUDs, and affordable sub-dermal contraceptive implants such as sino-implants. In 2013, the IUD sub-segment registered the largest market share due to the high usage of these devices in China and Europe. The contraceptive devices product segment is expected to rise at a CAGR of more than 3.5% in the forecast period, adds the report.
Geography-wise, the global market for contraceptives is divided into North America, Asia Pacific, Europe, and Rest of the World (RoW). In 2013, North America dominated the global market for contraceptives, due to the high incidence of unintended pregnancies, increased use of emergency contraceptive pills, and favorable reimbursement policies after the Affordable Care Act was launched.
Other Reports Published by Transparency Market Research:
- Global Implantable Drug Delivery Devices Market to Reach US$21.1 billion by 2018: http://www.transparencymarketresearch.com/pressrelease/implantable-drug-delivery-devices.htm
- Global Postpartum Hemorrhage Treatment Devices Market to reach USD 926.1 million in 2023: http://www.transparencymarketresearch.com/pressrelease/postpartum-hemorrhage-treatment-devices-market.htm
- Urinary Catheters Market to be Propelled by Rising Incidence of Urinary Disorders Worldwide: http://www.transparencymarketresearch.com/pressrelease/urinary-catheters-market.htm
The global contraceptives market is divided into:
Global Contraceptives Market, by Product Types
- Oral Contraceptive Pills
- Contraceptive Injectables
- Topical Contraceptives
- Male Contraceptive Devices (Male Condoms)
- Female Contraceptive Devices<
- Female Condoms
- Sub-dermal Contraceptive Implants
- Intrauterine Devices
- Contraceptive Vaginal Rings
- Contraceptive Diaphragm
- Contraceptive Sponges
- Non-Surgical Permanent Contraception Device
Global Contraceptives Market, by Geography
- North America
- Asia Pacific
- Rest of the World (RoW)
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
SOURCE Transparency Market Research